Table 1 Characteristics of studies included in the meta-analysis
Author (year) | Country | n | Age (years) | Males (%) | HCV genotype | HCV-AVT | HIV (%) | Sample type | Sample condition | GS cut-off (IU/ml) |
|---|---|---|---|---|---|---|---|---|---|---|
Mederacke et al. [40] | Germany | 57 | 40.5 | 73.0 | 1, 2, 3, 4 | NT | N/A | Serum/plasma | Frozen | 15 and 600 |
Alonso et al. [41] | Spain | 25 | 53.1 | 52.6 | 1, 2, 3, 4 | NT/OT | 75.0 | Serum | Unknown | 15 |
Duchesne et al. [42] | Cameroon | 107 | 40.6 | 49.0 | 1, 2, 3 | NT | 0.0 | Serum | Frozen | 12 |
Loggi et al. [43] | Italy | 35 | 58.0 | 74.2 | 1, 2, 3, 4 | OT | 0.0 | Serum | Unknown | 15 |
Mohamed et al. [44] | Tanzania | 14 | 34.0 | 92.2 | 1, 4 | NT | 50.0 | Serum | Frozen | 15 |
Wasitthankasem et al. [45] | Thailand | 13 | 45.2 | 69.2 | 1, 3, 6 | NT | 0.3 | Plasma | Unknown | 12 |
Alonso et al. [46] | Spain | 57 | N/A | N/A | 1, 2, 3, 4 | NT | 33.3 | Serum | Frozen | 15 |
Ponnuvel et al. [47] | India | 8 | 40.0 | 75.0 | 1, 3, 4 | NT | 0.0 | Plasma | Frozen | 12 |
Sun et al. [48] | Taiwan, China | 154 | 46.0 | 98.1 | 1, 2 | NT | 98.1 | Plasma | Unknown | 15 |
Ponnuvel et al. [49] | India | 19 | 48.0 | 68.4 | 1, 3, 4 | NT | 0.0 | Plasma | Frozen | 12 |